Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Calcium supplements improved bone deformities but not skin papules or hair loss.

PRS injections can improve knee function and reduce pain for up to a year.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

Two different mutations in the vitamin D receptor gene cause different symptoms and responses to treatment in Lebanese patients with hereditary rickets.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

Ritlecitinib is safe for treating alopecia areata for up to 48 weeks.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Spironolactone helps prevent swelling caused by minoxidil in women with hair loss.

Patients with this syndrome can have different responses and worsening resistance to treatment over time.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Finasteride reduces prostate size, improves urination, and slows prostate cancer progression.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

ZD1839 can cause skin issues like acne and hair changes.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Rheumatology clinics should always provide preconception counseling for women on DMARDs.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

The FDA did not approve a testosterone drug because of safety concerns.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Some acne medications have side effects; doctors should educate patients and may not need to do frequent lab tests for all.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Taking calcium may help elderly with osteoporosis, birth control with levonorgestrel doesn't increase heart attack risk, Salmonella can cause arthritis, a national ethics committee is recommended, and sulfasalazine might help with a hair loss condition.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Ritlecitinib works well and is safe for treating alopecia areata.

Spironolactone use is not linked to an increased risk of breast cancer, but caution is advised for high-risk patients.

The drug combination was safe and showed promise in treating advanced tumors.

The document's conclusion cannot be provided because the document is not available or cannot be read.